세계의 심전도(ECG) 기계 시장 예측(2025-2030년)

The Electrocardiogram (ECG) Machine Market is set to increase from USD 7.321 billion in 2025 to USD 9.242 billion by 2030, at a CAGR of 4.77%.

The global electrocardiogram (ECG) machine market is poised for robust growth, driven by the escalating prevalence of cardiovascular diseases (CVDs), an aging population, and advancements in portable monitoring technologies. ECG machines, including resting ECG, stress ECG, and Holter monitors, provide non-invasive recordings of the heart's electrical activity, enabling early detection of abnormalities. The market benefits from increasing demand for continuous cardiac monitoring amid rising obesity rates and lifestyle-related risks. Technological innovations, such as handheld and home-use devices, enhance accessibility, allowing patients to monitor heart health remotely, reducing the need for frequent hospital visits. Substantial R&D investments by key players are fostering error-free, advanced systems, further propelling market expansion.

Market Drivers

Increasing Incidence of Cardiovascular Diseases

The rising global burden of CVDs is a primary growth catalyst, necessitating widespread ECG monitoring for diagnosis and management. As the leading cause of mortality, CVDs underscore the demand for reliable cardiac assessment tools. This trend amplifies the need for ECG machines in clinical and home settings, driving market adoption as healthcare providers prioritize preventive and ongoing surveillance to mitigate risks associated with heart conditions.

Expanding Geriatric Population

The global geriatric population, projected by the United Nations to reach 1.5 billion by 2050, significantly fuels market growth. Older individuals are at higher risk for cardiac issues, requiring regular ECG monitoring to ensure timely interventions. This demographic shift increases the volume of cardiac evaluations, boosting demand for user-friendly, portable ECG solutions tailored to aging populations.

Market Segments and Geographical Outlook

By type, Holter monitors are expected to dominate, valued for their portability and ability to record continuous heart activity over extended periods outside hospital environments. By end-user, hospitals hold a substantial share, driven by the high volume of CVD-related treatments and surgeries requiring ECG support. Geographically, the Asia-Pacific region is anticipated to exhibit the highest compound annual growth rate (CAGR), supported by rising investments in healthcare infrastructure and a growing geriatric demographic in countries like Japan and India. North America maintains a notable market position, bolstered by a mature healthcare ecosystem and presence of leading manufacturers.

Market Restraints

Unfavorable reimbursement policies pose a significant challenge, as many insurers and providers do not cover ECG procedures, rendering them cost-prohibitive for patients. This reluctance can deter adoption, particularly among those without comprehensive coverage, potentially limiting market penetration and growth in both developed and emerging regions.

Competitive Landscape

Key market leaders include Koninklijke Philips N.V., CardioComm Solutions, Inc., SCHILLER AG, Nihon Kohden Corporation, Mortara Instrument, General Electric Company, and BioTelemetry, Inc. These players pursue strategies such as product launches, mergers, and acquisitions to enhance their portfolios and maintain competitive advantages. Focus areas include developing integrated, AI-enhanced ECG systems for improved accuracy and remote capabilities.

Market Outlook

The ECG machine market is set for sustained expansion through 2030, propelled by CVD prevalence, demographic trends, and technological portability. Asia-Pacific's rapid growth contrasts with North America's established dominance, highlighting opportunities for innovation in home-based monitoring. Industry stakeholders must address reimbursement hurdles through advocacy and cost-optimization strategies to fully capitalize on the rising demand for accessible cardiac diagnostics, ensuring broader adoption amid evolving healthcare needs.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Component

• Hardware
• Software
• Services

By Type

• Resting ECG Machine
• Portable ECG Machine
• Stress ECG Machine
• Others

By Lead Type

• 1-Lead
• 3-Lead
• 6-Lead
• 12-Lead

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY COMPONENT

• 5.1. Introduction
• 5.2. Hardware
• 5.3. Software
• 5.4. Services

6. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY TYPE

• 6.1. Introduction
• 6.2. Resting ECG Machine
• 6.3. Portable ECG Machine
• 6.4. Stress ECG Machine
• 6.5. Others

7. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY LEAD TYPE

• 7.1. Introduction
• 7.2. 1-Lead
• 7.3. 3-Lead
• 7.4. 6-Lead
• 7.5. 12-Lead

8. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Ambulatory Surgical Centers
• 8.4. Others

9. GLOBAL ELECTROCARDIOGRAM (ECG) MACHINE MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Italy
  • 9.4.5. Spain
  • 9.4.6. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Israel
  • 9.5.4. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Taiwan
  • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. GE Healthcare
• 11.2. Koninklijke Philips N.V.
• 11.3. CardioComm Solutions, Inc
• 11.4. SCHILLER AG
• 11.5. Nihon Kohden Corporation
• 11.6. Baxter International
• 11.7. OSI System Inc.
• 11.8. Fukuda Denshi Co., Ltd.
• 11.9. Allengers
• 11.10. VectraCor

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations